Search for chemical structures by a sketch :Ethyl nicotinate

Recommanded Product: Ethyl nicotinate. About Ethyl nicotinate, If you have any questions, you can contact Liu, JJ; Chen, JY; Li, SS; Tian, WN; Wu, HG; Han, BZ or concate me.

Recommanded Product: Ethyl nicotinate. Authors Liu, JJ; Chen, JY; Li, SS; Tian, WN; Wu, HG; Han, BZ in TAYLOR & FRANCIS INC published article about in [Liu, Jingjing; Li, Shuangshi; Tian, Weina] Beijing Polytech, Sch Bioengn, Dept Food Technol, Beijing, Peoples R China; [Chen, Jingyu; Han, Beizhong] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing Lab Food Qual & Safety, Beijing, Peoples R China; [Wu, Haigang] Henan Univ, Sch Life Sci, Kaifeng, Henan, Peoples R China in 2021, Cited 32. The Name is Ethyl nicotinate. Through research, I have a further understanding and discovery of 614-18-6

Sufu is a pleasant-tasting, traditional Chinese fermented soybean food that is rich in nutrients. In this study, the changes of volatile and nonvolatile metabolites in sufu fermented by bacillus licheniformis, were investigated. The results indicated that a total of 55 kinds of nonvolatile compounds were detected, including 2 carbohydrates, 4 alcohols, 17 amino acids, 18 organic acids, 6 biogenic amines, and 8 other substances. Furthermore, a total of 58 volatile compounds identified were composed of 11 esters, 16 alcohols, 10 acids, and 21 miscellaneous compounds. Inoculation of bacillus licheniformis enriched the metabolite pro?le of sufu and improved its functionality and safety of edibility. It was observed that the pure fermented starter resulted in controlled acceleration of sufu maturation.

Recommanded Product: Ethyl nicotinate. About Ethyl nicotinate, If you have any questions, you can contact Liu, JJ; Chen, JY; Li, SS; Tian, WN; Wu, HG; Han, BZ or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Our Top Choice Compound:Phenyl(pyridin-2-yl)methanone

Quality Control of Phenyl(pyridin-2-yl)methanone. About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Li, YL; Gan, XL; Zhu, RP; Wang, XH; Liao, DF; Jin, JF; Huang, ZQ or concate me.

I found the field of Oncology; Pharmacology & Pharmacy very interesting. Saw the article Anticancer Activity of Platinum (II) Complex with 2-Benzoylpyridine by Induction of DNA Damage, S-Phase Arrest, and Apoptosis published in 2020.0. Quality Control of Phenyl(pyridin-2-yl)methanone, Reprint Addresses Jin, JF (corresponding author), Guilin Med Univ, Affiliated Hosp, Lab Hepatobiliary & Pancreat Surg, Guilin 541001, Guangxi, Peoples R China.; Huang, ZQ (corresponding author), Guilin Med Univ, Dept Pathol, Affiliated Hosp, 15 Lequn Rd, Guilin 541001, Guangxi, Peoples R China.. The CAS is 91-02-1. Through research, I have a further understanding and discovery of Phenyl(pyridin-2-yl)methanone

Objective: To overcome the disadvantages of cisplatin, numerous platinum (Pt) complexes have been prepared. However, the anticancer activity and mechanism of Pt(II) complexed with 2-benzoylpyridine [Pt(II)-Bpy]: [PtCl2(DMSO)L] (DMSO = dimethyl sulfoxide, L = 2-benzoylpyridine) in cancer cells remain unknown. Methods: Pt(II)-Bpy was synthesized and characterized by spectrum analysis. Its anticancer activity and underlying mechanisms were demonstrated at the cellular, molecular, and in vivo levels. Results: Pt(II)-Bpy inhibited tumor cell growth, especially HepG2 human liver cancer cells, with a half-maximal inhibitory concentration of 9.8 +/- 0.5 mu M, but with low toxicity in HL-7702 normal liver cells. Pt(H)Bpy induced DNA damage, which was demonstrated through a marked increase in the expression of cleaved-poly (ADP ribose) polymerase (PARP) and gamma-H2A histone family member X and a decrease in PARP expression. The interaction of Pt(II)-Bpy with DNA at the molecular level was most likely through an intercalation mechanism, which might be evidence of DNA damage. Pt(II)-Bpy initiated cell cycle arrest at the S phase in HepG2 cells. It also caused severe loss of the mitochondria( membrane potential; a decrease in the expression of caspase-9 and caspase-3; an increase in reactive oxygen species levels; the release of cytochrome c and apoptotic protease activation factor; and the activation of caspase-9 and caspase-3 in HepG2 cells, which in turn resulted in apoptosis. Meanwhile, changes in p53 and related proteins were observed including the upregulation of p53, the phosphorylation of p53, p21, B-cell lymphoma-2-associated X protein, and NOXA; and the down-regulation of B-cell lymphoma 2. Moreover, Pt(II)-Bpy displayed marked inhibitory effects on tumor growth in the HepG2 nude mouse model. Conclusion: Pt(II)-Bpy is a potential candidate for cancer chemotherapy.

Quality Control of Phenyl(pyridin-2-yl)methanone. About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Li, YL; Gan, XL; Zhu, RP; Wang, XH; Liao, DF; Jin, JF; Huang, ZQ or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Simple exploration of Phenyl(pyridin-2-yl)methanone

Safety of Phenyl(pyridin-2-yl)methanone. About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Araujo, VO; Tirloni, B; Streit, L; Schwade, VD or concate me.

Safety of Phenyl(pyridin-2-yl)methanone. In 2019.0 ACTA CRYSTALLOGR C published article about SUPEROXIDE-DISMUTASE ACTIVITY; DOT-N INTERACTIONS; COPPER(II) COMPLEXES; CRYSTAL-STRUCTURE in [Araujo, Vinicius Oliveira; Schwade, Vania Denise] Fundacao Univ Fed Grande Dourados, Fac Ciencias Exatas & Tecnol, Rodovia Dourados Itahum,Km 12, BR-79804970 Dourados, MS, Brazil; [Tirloni, Brbara] Univ Fed Santa Maria, Dept Quim, Ave Roraima 1000, BR-97105900 Santa Maria, RS, Brazil; [Streit, Livia] Univ North Georgia, Dept Chem & Biochem, 3820 Mundy Mill Rd, Oakwood, GA 30566 USA in 2019.0, Cited 22.0. The Name is Phenyl(pyridin-2-yl)methanone. Through research, I have a further understanding and discovery of 91-02-1.

Semicarbazones can exist in two tautomeric forms. In the solid state, they are found in the keto form. This work presents the synthesis, structures and spectroscopic characterization (IR and NMR spectroscopy) of four such compounds, namely the neutral molecule 4-phenyl-1-[phenyl(pyridin-2-yl)methylidene] semicarbazide, C19H16N4O, (I), abbreviated as HBzPyS, and three different hydrated salts, namely the chloride dihydrate, C19H17N4O+center dot Cl-center dot 2H(2)O, (II), the nitrate dihydrate, C19H17N4O+center dot NO3-center dot 2H(2)O, (III), and the thiocyanate 2.5-hydrate, C19H17N4O+center dot SCN-center dot 2.5H(2)O, (IV), of 2-[phenyl({[(phenylcarbamoyl) amino]imino})methyl]pyridinium, abbreviated as [H(2)BzPyS](+)center dot X-center dot nH(2)O, with X = Cl- and n = 2 for (II), X= NO3- and n = 2 for (III), and X = SCN- and n = 2.5 for (IV), showing the influence of the anionic form in the intermolecular interactions. Water molecules and counter-ions (chloride or nitrate) are involved in the formation of a two-dimensional arrangement by the establishment of hydrogen bonds with the N-H groups of the cation, stabilizing the E isomers in the solid state. The neutral HBzPyS molecule crystallized as the E isomer due to the existence of weak pi-pi interactions between pairs of molecules. The calculated IR spectrum of the hydrated [H(2)BzPyS](+) cation is in good agreement with the experimental results.

Safety of Phenyl(pyridin-2-yl)methanone. About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Araujo, VO; Tirloni, B; Streit, L; Schwade, VD or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Chemical Properties and Facts of C12H9NO

Quality Control of Phenyl(pyridin-2-yl)methanone. About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Ampawa, S; Krittametaporn, N; Ungpittagul, T; Phomphrai, K; Sangtrirutnugul, P or concate me.

Quality Control of Phenyl(pyridin-2-yl)methanone. I found the field of Chemistry very interesting. Saw the article Triazole-based ligands functionalized silica: Effects of ligand denticity and donors on catalytic oxidation activity of Pd nanoparticles published in 2019.0, Reprint Addresses Sangtrirutnugul, P (corresponding author), Mahidol Univ, Ctr Excellence Innovat Chem PERCH CIC, Ctr Catalysis, Dept Chem,Fac Sci, 272 Rama VI Rd, Bangkok 10400, Thailand.. The CAS is 91-02-1. Through research, I have a further understanding and discovery of Phenyl(pyridin-2-yl)methanone.

Triazole-based ligands, tris (triazolyl)methanol (Htbtm), bis (triazolyl)-phenylmethanol (Hbtm), and phenyl (pyridin-2-yl)(triazolyl)methanol (Hpytm), with differences in ligand denticity (i.e., bidentate and tridentate) and type of N donors (i.e., triazole and pyridine) were functionalized onto a silica support to produce the corresponding SiO2-L (L = tbtm, btm, pytm). Subsequent reactions with Pd (CH3COO)(2) in CH2Cl2 yielded Pd/SiO2-L. ICP-MS reveals that Pd loadings are higher with increased N loadings, resulting in the following trend: Pd/SiO2-tbtm (0.83 mmol Pd g(-1)) > Pd/SiO2-btm (0.65 mmol Pd g(-1)) ~ Pd/SiO2-pytm (0.63 mmol Pd g(-1)). Meanwhile, TEM images of the used Pd/SiO2-L catalysts after the first catalytic cycle show that the mean size of Pd NPs is highest with Pd/SiO2-pytm (8.5 +/- 1.5 nm), followed by Pd/SiO2-tbtm (6.4 +/- 1.6 nm) and Pd/SiO2-btm (4.8 +/- 1.3 nm). Based on TONs, catalytic studies toward aerobic oxidation of benzyl alcohol to benzaldehyde at 60 degrees C in EtOH showed that Pd/SiO2-pytm possessed the most active surface Pd(0) atoms, most likely as a result of more labile properties of the pyridine-triazole ligand compared to tris- and bis (triazolyl) analogs. ICP-MS and TEM analysis of Pd/SiO2-btm indicate minimal Pd leaching and similar average Pd NPs sizes after 1(st) and 5(th) catalytic runs, respectively, confirming that SiO2-btm is an efficient Pd NPs stabilizer. The Pd/SiO2-btm catalyst was also active toward aerobic oxidation of various benzyl alcohol derivatives in EtOH and could be reused for at least 7 reaction cycles without a significant activity loss.

Quality Control of Phenyl(pyridin-2-yl)methanone. About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Ampawa, S; Krittametaporn, N; Ungpittagul, T; Phomphrai, K; Sangtrirutnugul, P or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

What Kind of Chemistry Facts Are We Going to Learn About Phenyl(pyridin-2-yl)methanone

About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Weng, WZ; Guo, JS; Liu, KX; Shao, TQ; Song, LQ; Zhu, YP; Sun, YY; Meng, QG or concate me.. SDS of cas: 91-02-1

I found the field of Chemistry very interesting. Saw the article Metal-free oxidative C(sp(3))-H functionalization: a facile route to quinoline formaldehydes from methyl-azaheteroarenes published in 2020.0. SDS of cas: 91-02-1, Reprint Addresses Zhu, YP; Sun, YY; Meng, QG (corresponding author), Yantai Univ, Collaborat Innovat Ctr Adv Drug Delivery Syst & B, Minist Educ, Sch Pharm,Key Lab Mol Pharmacol & Drug Evaluat, Yantai 264005, Shandong, Peoples R China.. The CAS is 91-02-1. Through research, I have a further understanding and discovery of Phenyl(pyridin-2-yl)methanone

A facile protocol for the synthesis of quinoline formaldehydes via direct oxidative C-H bonds functionalization of methyl-azaheteroarenes in the presence of I-2-DMSO has been described. This method is metal-free and easy to operate. This reaction provided a convenient route for the preparation of a range of important quinoline formaldehydes.

About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Weng, WZ; Guo, JS; Liu, KX; Shao, TQ; Song, LQ; Zhu, YP; Sun, YY; Meng, QG or concate me.. SDS of cas: 91-02-1

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

The important role of C8H10ClNO3

About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Poladian, Q; Sahin, O; Karakurt, T; Ilhan-Ceylan, B; Kurt, Y or concate me.. COA of Formula: C8H10ClNO3

Poladian, Q; Sahin, O; Karakurt, T; Ilhan-Ceylan, B; Kurt, Y in [Poladian, Qumars; Ilhan-Ceylan, Berat; Kurt, Yasemin] Istanbul Univ Cerrahpasa, Engn Fac, Dept Chem, TR-34320 Istanbul, Turkey; [Sahin, Onur] Sinop Univ, Fac Hlth Sci, Dept Occupat Hlth & Safety, TR-57000 Sinop, Turkey; [Karakurt, Tuncay] Kirsehir Ahi Evran Univ, Fac Engn Architecture, Dept Chem & Proc Engn, TR-40100 Kirsehir, Turkey published A new zinc(II) complex with N2O2-tetradentate schiff-base derived from pyridoxal-S-methylthiosemicarbazone: Synthesis, characterization, crystal structure, DFT, molecular docking and antioxidant activity studies in 2021.0, Cited 69.0. COA of Formula: C8H10ClNO3. The Name is 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. Through research, I have a further understanding and discovery of 65-22-5.

A new unsymmetrical N2O2-tetradentate Schiff-base complex of zinc(II) was synthesized by the template reaction of pyridoxal-S-methylthiosemicarbazone and 2-hydroxy-4-methoxy-benzaldehyde as starting compounds. S-methylthiosemicarbazone (1) and zinc(II) complex [Zn(L)CH3OH] ( 2) were characterized by elemental analysis, FT-IR, UV-visible, H-1, and C-13 NMR spectra. The molecular structure of the complex (2) was determined by single crystal X-ray diffraction technique. The structure consists of a distorted square-pyramidal geometry around the central metal, Zn(II). Quantum chemical calculations were carried out using density functional theory DFT/B3LYP, 6-31G (d), and LanL2DZ basis sets for theoretical characterization of the compounds. The experimental and theoretical data were compared comprehensively. The potential energy distribution (PED) analysis was performed for the assignment of vibration frequencies. In order to support in vitro studies, molecular docking studies have been carried out so that the title compound can be an inhibitor of Epidermal Growth Factor Receptor (1 m17), and the relationship between calculated HOMO energies and docking studies has been examined. In addition, the total antioxidant capacity (as TEAC value) and free radical scavenging activity of the compounds were determined by Cupric Reducing Antioxidant Capacity (CUPRAC) and 1,1-diphenyl-2-picryl hydrazyl (DPPH) methods, respectively. (C) 2021 Elsevier Ltd. All rights reserved.

About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Poladian, Q; Sahin, O; Karakurt, T; Ilhan-Ceylan, B; Kurt, Y or concate me.. COA of Formula: C8H10ClNO3

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Never Underestimate The Influence Of C6H5NO

HPLC of Formula: C6H5NO. About 3-Pyridinecarboxaldehyde, If you have any questions, you can contact Ben Gaied, L; Fincias, N; Garrec, J; El Kaim, L or concate me.

HPLC of Formula: C6H5NO. Ben Gaied, L; Fincias, N; Garrec, J; El Kaim, L in [Ben Gaied, Lilia] Inst Preparatoire Etud Sci & Tech, Lab Physicochim Microstruct & Microsyst, BP 51, Tunis 2070, Tunisia; [Fincias, Nicolas; Garrec, Julian; El Kaim, Laurent] Inst Polytech Paris, LSO, Ecole Polytech, CNRS,ENSTA Paris UMR 7652, 828 Bd Marechaux, F-91128 Palaiseau, France published 5-endo-dig Cyclization of O-Propargyl Mandelic Acid Amides towards 2,5-Dihydrofurans in 2019.0, Cited 71.0. The Name is 3-Pyridinecarboxaldehyde. Through research, I have a further understanding and discovery of 500-22-1.

5-endo-dig cyclization of O-propargyloxyamides, obtained through a Passerini reaction mediated by boric acid and subsequent propargylation, affords 2,5-dihydrofurans in the presence of tert-butylate. The mechanism of the reaction was studied by using DFT calculations and the results were compared with the behavior of analogous N-propargylamide derivatives.

HPLC of Formula: C6H5NO. About 3-Pyridinecarboxaldehyde, If you have any questions, you can contact Ben Gaied, L; Fincias, N; Garrec, J; El Kaim, L or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Can You Really Do Chemisty Experiments About Phenyl(pyridin-2-yl)methanone

COA of Formula: C12H9NO. About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Kondo, Y; Kadota, T; Hirazawa, Y; Morisaki, K; Morimoto, H; Ohshima, T or concate me.

In 2020.0 ORG LETT published article about MANNICH-TYPE REACTIONS; BOND FORMATION; ARYL HALIDES; ALPHA-AMINO; ASYMMETRIC HYDROGENATION; BENZOPHENONE IMINE; DIRECT ACCESS; SCHIFF-BASES; DERIVATIVES; ACTIVATION in [Kondo, Yuta; Kadota, Tetsuya; Hirazawa, Yoshinobu; Morisaki, Kazuhiro; Morimoto, Hiroyuki; Ohshima, Takashi] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan; [Morisaki, Kazuhiro] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan in 2020.0, Cited 67.0. The Name is Phenyl(pyridin-2-yl)methanone. Through research, I have a further understanding and discovery of 91-02-1. COA of Formula: C12H9NO

N-Unprotected ketimines are useful substrates and intermediates for synthesizing valuable nitrogen-containing compounds, but their potential applicability is limited by the available synthetic methods. To address this issue, we report a scandium(III) triflate catalyzed direct synthesis of N-unprotected ketimines. Using commercially available reagents and Lewis acid catalysts, ketones were directly transformed into the corresponding N-unprotected ketimines in high yields with broad functional group tolerance, even in multigram scales. The reactions were readily applicable for one-pot synthesis of important compounds such as a glycine Schiff base without isolation of N-unprotected ketimine intermediates. Preliminary mechanistic studies to clarify the reaction mechanism are also described.

COA of Formula: C12H9NO. About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Kondo, Y; Kadota, T; Hirazawa, Y; Morisaki, K; Morimoto, H; Ohshima, T or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Brief introduction of 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride

Formula: C8H10ClNO3. About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Imamura, F; Fretts, AM; Marklund, M; Ardisson Korat, AV; Yang, WS; Lankinen, M; Qureshi, W; Helmer, C; Chen, TA; Virtanen, JK; Wong, K; Bassett, JK; Murphy, R; Tintle, N; Yu, CI; Brouwer, IA; Chien, KL; Chen, Yy; Wood, AC; del Gobbo, LC; Djousse, L; Geleijnse, JM; Giles, GG; de Goede, J; Gudnason, V; Harris, WS; Hodge, A; Hu, F; Koulman, A; Laakso, M; Lind, L; Lin, HJ; McKnight, B; Rajaobelina, K; Riserus, U; Robinson, JG; Samieri, C; Senn, M; Siscovick, DS; Soedamah-Muthu, SS; Sotoodehnia, N; Sun, Q; Tsai, MY; Tuomainen, TP; Uusitupa, M; Wagenknecht, LE; Wareham, NJ; Wu, JHY; Micha, R; Lemaitre, RN; Mozaffarian, D; Forouhi, NG or concate me.

An article Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies WOS:000559724500001 published article about CORONARY-HEART-DISEASE; BETA-CELL TURNOVER; ADIPOSE-TISSUE; COFFEE CONSUMPTION; PLASMA; RISK; ASSOCIATION; BIOMARKERS; CANCER; PHOSPHOLIPIDS in [Imamura, Fumiaki; Koulman, Albert; Wareham, Nick J.; Forouhi, Nita G.] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [Fretts, Amanda M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Marklund, Matti; Riserus, Ulf] Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Nutr & Metab, Uppsala, Sweden; [Marklund, Matti; Wu, Jason H. Y.] Univ New South Wales, George Inst Global Hlth, Fac Med, Sydney, NSW, Australia; [Marklund, Matti; Micha, Renata; Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Ardisson Korat, Andres V.; Hu, Frank] Harvard TH Chan Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA USA; [Ardisson Korat, Andres V.; Hu, Frank; Sun, Qi] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Ardisson Korat, Andres V.; Djousse, Luc; Hu, Frank; Sun, Qi] Harvard Med Sch, Boston, MA 02115 USA; [Yang, Wei-Sin; Chien, Kuo-Liong; Chen, Yun-yu] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan; [Lankinen, Maria; Virtanen, Jyrki K.; Tuomainen, Tomi-Pekka; Uusitupa, Matti] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Qureshi, Waqas] Wake Forest Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, Winston Salem, NC 27101 USA; [Helmer, Catherine; Rajaobelina, Kalina; Samieri, Cecilia] Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM, UMR 1219, Bordeaux, France; [Chen, Tzu-An; Wood, Alexis C.; Senn, Mackenzie] USDA ARS, Childrens Nutr Res Ctr, Dept Pediat, Baylor Coll Med, Houston, TX USA; [Wong, Kerry; Bassett, Julie K.; Giles, Graham G.; Hodge, Allison] Canc Council Victoria, Canc Epidemiol Div, Melbourne, Vic, Australia; [Murphy, Rachel] Univ British Columbia, Sch Populat Publ & Hlth, Ctr Excellence Canc Prevent, Fac Med, Vancouver, BC, Canada; [Tintle, Nathan] Dordt Univ, Dept Math & Stat, Sioux Ctr, IA USA; [Yu, Chaoyu Ian; McKnight, Barbara] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [Brouwer, Ingeborg A.] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Hlth Sci, Fac Sci, Amsterdam, Netherlands; [Chien, Kuo-Liong; Chen, Yun-yu] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [del Gobbo, Liana C.] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Djousse, Luc] Brigham & Womens Hosp, Dept Med, Div Aging, 75 Francis St, Boston, MA 02115 USA; [Geleijnse, Johanna M.; de Goede, Janette; Soedamah-Muthu, Sabita S.] Wageningen Univ, Div Human Nutr & Hlth, Wageningen, Netherlands; [Giles, Graham G.; Hodge, Allison] Univ Melbourne, Ctr Epidemiol & Biostat, Parkville, Vic, Australia; [Giles, Graham G.] Monash Univ, Sch Clin Sci Monash Hlth, Precis Med, Clayton, Vic, Australia; [Gudnason, Vilmundur] Iceland Heart Assoc Res Inst, Kopavogur, Iceland; [Harris, William S.] Univ South Dakota, Sanford Sch Med, Dept Internal Med, Sioux Falls, SD USA; [Harris, William S.] OmegaQuant Analyt, Sioux Falls, SD USA; [Koulman, Albert] Univ Cambridge, Natl Inst Hlth Res, Addenbrookes Hosp, Biomed Res Ctr,Core Nutr Biomarker Lab, Cambridge, England; [Koulman, Albert] Univ Cambridge, Natl Inst Hlth Res, Addenbrookes Hosp, Biomed Res Ctr,Core Metabol & Lipid Lab, Cambridge, England; [Koulman, Albert] MRC, Elsie Widdowson Lab, Cambridge, England; [Laakso, Markku] Univ Eastern Finland, Inst Clin Med, Internal Med, Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, Dept Med, Kuopio, Finland; [Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Lin, Hung-Ju] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Robinson, Jennifer G.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Prevent Intervent Ctr, Iowa City, IA USA; [Siscovick, David S.] New York Acad Med, New York, NY USA; [Soedamah-Muthu, Sabita S.] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol & Somat Disorders, Tilburg, Netherlands; [Soedamah-Muthu, Sabita S.] Univ Reading, Inst Food Nutr & Hlth, Reading, Berks, England; [Sotoodehnia, Nona; Lemaitre, Rozenn N.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Tsai, Michael Y.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Wagenknecht, Lynne E.] Wake Forest Sch Med, Publ Hlth Sci, Winston Salem, NC 27101 USA in 2020.0, Cited 47.0. The Name is 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. Through research, I have a further understanding and discovery of 65-22-5. Formula: C8H10ClNO3

Background De novo lipogenesis (DNL) is the primary metabolic pathway synthesizing fatty acids from carbohydrates, protein, or alcohol. Our aim was to examine associations of in vivo levels of selected fatty acids (16:0, 16:1n7, 18:0, 18:1n9) in DNL with incidence of type 2 diabetes (T2D). Methods and findings Seventeen cohorts from 12 countries (7 from Europe, 7 from the United States, 1 from Australia, 1 from Taiwan; baseline years = 1970-1973 to 2006-2010) conducted harmonized individual-level analyses of associations of DNL-related fatty acids with incident T2D. In total, we evaluated 65,225 participants (mean ages = 52.3-75.5 years; % women = 20.4%62.3% in 12 cohorts recruiting both sexes) and 15,383 incident cases of T2D over the 9-year follow-up on average. Cohort-specific association of each of 16:0, 16:1n7, 18:0, and 18:1n9 with incident T2D was estimated, adjusted for demographic factors, socioeconomic characteristics, alcohol, smoking, physical activity, dyslipidemia, hypertension, menopausal status, and adiposity. Cohort-specific associations were meta-analyzed with an inverse-varianceweighted approach. Each of the 4 fatty acids positively related to incident T2D. Relative risks (RRs) per cohort-specific range between midpoints of the top and bottom quintiles of fatty acid concentrations were 1.53 (1.41-1.66; p< 0.001) for 16:0, 1.40 (1.33-1.48; p< 0.001) for 16:1n-7, 1.14 (1.05-1.22; p = 0.001) for 18:0, and 1.16 (1.07-1.25; p< 0.001) for 18:1n9. Heterogeneity was seen across cohorts (I-2 = 51.1%-73.1% for each fatty acid) but not explained by lipid fractions and global geographical regions. Further adjusted for triglycerides (and 16:0 when appropriate) to evaluate associations independent of overall DNL, the associations remained significant for 16:0, 16:1n7, and 18:0 but were attenuated for 18:1n9 (RR = 1.03, 95% confidence interval (CI) = 0.94-1.13). These findings had limitations in potential reverse causation and residual confounding by imprecisely measured or unmeasured factors. Conclusions Concentrations of fatty acids in the DNL were positively associated with T2D incidence. Our findings support further work to investigate a possible role of DNL and individual fatty acids in the development of T2D. Formula: C8H10ClNO3. About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Imamura, F; Fretts, AM; Marklund, M; Ardisson Korat, AV; Yang, WS; Lankinen, M; Qureshi, W; Helmer, C; Chen, TA; Virtanen, JK; Wong, K; Bassett, JK; Murphy, R; Tintle, N; Yu, CI; Brouwer, IA; Chien, KL; Chen, Yy; Wood, AC; del Gobbo, LC; Djousse, L; Geleijnse, JM; Giles, GG; de Goede, J; Gudnason, V; Harris, WS; Hodge, A; Hu, F; Koulman, A; Laakso, M; Lind, L; Lin, HJ; McKnight, B; Rajaobelina, K; Riserus, U; Robinson, JG; Samieri, C; Senn, M; Siscovick, DS; Soedamah-Muthu, SS; Sotoodehnia, N; Sun, Q; Tsai, MY; Tuomainen, TP; Uusitupa, M; Wagenknecht, LE; Wareham, NJ; Wu, JHY; Micha, R; Lemaitre, RN; Mozaffarian, D; Forouhi, NG or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

You Should Know Something about 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride

Application In Synthesis of 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Poladian, Q; Sahin, O; Karakurt, T; Ilhan-Ceylan, B; Kurt, Y or concate me.

Application In Synthesis of 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. In 2021.0 POLYHEDRON published article about TRANSITION-METAL-COMPLEXES; EFFECTIVE CORE POTENTIALS; GROWTH-FACTOR RECEPTOR; THIOSEMICARBAZONE DERIVATIVES; BIOLOGICAL-ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; COPPER(II) COMPLEXES; LIGANDS; NICKEL(II); ANTITUMOR in [Poladian, Qumars; Ilhan-Ceylan, Berat; Kurt, Yasemin] Istanbul Univ Cerrahpasa, Engn Fac, Dept Chem, TR-34320 Istanbul, Turkey; [Sahin, Onur] Sinop Univ, Fac Hlth Sci, Dept Occupat Hlth & Safety, TR-57000 Sinop, Turkey; [Karakurt, Tuncay] Kirsehir Ahi Evran Univ, Fac Engn Architecture, Dept Chem & Proc Engn, TR-40100 Kirsehir, Turkey in 2021.0, Cited 69.0. The Name is 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. Through research, I have a further understanding and discovery of 65-22-5.

A new unsymmetrical N2O2-tetradentate Schiff-base complex of zinc(II) was synthesized by the template reaction of pyridoxal-S-methylthiosemicarbazone and 2-hydroxy-4-methoxy-benzaldehyde as starting compounds. S-methylthiosemicarbazone (1) and zinc(II) complex [Zn(L)CH3OH] ( 2) were characterized by elemental analysis, FT-IR, UV-visible, H-1, and C-13 NMR spectra. The molecular structure of the complex (2) was determined by single crystal X-ray diffraction technique. The structure consists of a distorted square-pyramidal geometry around the central metal, Zn(II). Quantum chemical calculations were carried out using density functional theory DFT/B3LYP, 6-31G (d), and LanL2DZ basis sets for theoretical characterization of the compounds. The experimental and theoretical data were compared comprehensively. The potential energy distribution (PED) analysis was performed for the assignment of vibration frequencies. In order to support in vitro studies, molecular docking studies have been carried out so that the title compound can be an inhibitor of Epidermal Growth Factor Receptor (1 m17), and the relationship between calculated HOMO energies and docking studies has been examined. In addition, the total antioxidant capacity (as TEAC value) and free radical scavenging activity of the compounds were determined by Cupric Reducing Antioxidant Capacity (CUPRAC) and 1,1-diphenyl-2-picryl hydrazyl (DPPH) methods, respectively. (C) 2021 Elsevier Ltd. All rights reserved.

Application In Synthesis of 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Poladian, Q; Sahin, O; Karakurt, T; Ilhan-Ceylan, B; Kurt, Y or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem